{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01995",
      "entity_text" : "cyclin-D1/D2",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01985",
      "entity_text" : "miR-340",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Furthermore, miR-340 has been shown to inhibit the progression of glioma by targeting cyclin dependent kinase 6, cyclin-D1/D2 and tissue plasminogen activator.",
  "reading_complete" : "2020-08-02T13:58:31Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T13:57:50Z",
  "trigger" : "inhibit",
  "evidence" : [ "miR-340 has been shown to inhibit the progression of glioma by targeting cyclin-dependent kinase 6, cyclin-D1/D2" ],
  "pmc_id" : "6605470",
  "score" : 0
}